Delving into the Latest Updates on Comité de lénergie Atomique with Synapse

Overview

Tags

Urogenital Diseases

Immune System Diseases

Infectious Diseases

Synthetic peptide

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	4
Infectious Diseases	4

Top 5 Drug Type	Count

Synthetic peptide	3
Small molecule drug	2

Top 5 Target	Count

ACE(Angiotensin-converting enzyme)	1
CD4(T-cell surface antigen CD4)	1
CD4 x ITIH4	1
HIV envelope protein gp120	1

This study aim is to propose operational conditions for the dilute acid pretreatment of rice straw and to explore the effect of the structural properties of the solid residues on the enzymatic hydrolysis. A maximal sugar yield of 83% was achieved when the rice straw was pretreated with 1% (w/w) sulfuric acid with a reaction time of 1-5 min at 160 degrees C or 180 degrees C, followed by enzymatic hydrolysis. The completely release of sugar (xylose and glucose) increased the pore volume of the pretreated solid residues resulted in an efficiency of 70% for the enzymatic hydrolysis. The extra pore volume was generated by the release of acid-soluble lignin and this resulted in the enzymatic hydrolysis being enhanced by nearly 10%. The increase in the crystallinity index of the pretreated rice straw was limited. These results were consistent with those from the Fourier transformer infrared (FTIR) analysis.

100 Deals associated with Comité de lénergie Atomique

Login to view more data

100 Translational Medicine associated with Comité de lénergie Atomique

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

5

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

CD4M47	HIV Infections More	Preclinical
CD4M33 ( CD4 x ITIH4 )	HIV Infections More	Preclinical
M48U12 ( HIV envelope protein gp120 )	HIV Infections More	Preclinical
RXPA380 ( ACE )	Hypertension More	Preclinical
CD4M9 ( CD4 )	HIV Infections More	Preclinical